Form 8-K - Current report:
SEC Accession No. 0001193125-21-327327
Filing Date
2021-11-12
Accepted
2021-11-12 07:23:02
Documents
14
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d257518d8k.htm   iXBRL 8-K 30202
2 EX-99.1 d257518dex991.htm EX-99.1 73560
6 GRAPHIC g257518dsp6.jpg GRAPHIC 4579
  Complete submission text file 0001193125-21-327327.txt   244014

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20211112.xsd EX-101.SCH 2925
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20211112_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20211112_pre.xml EX-101.PRE 11430
7 EXTRACTED XBRL INSTANCE DOCUMENT d257518d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211399559
SIC: 2834 Pharmaceutical Preparations